Experiments for taxon Cephalotaxus hainanensis (CEPHALOTAXACEAE)

Experiments (50 results)

Filters
Worktypes (14)
28
25
10
9
9
8
8
6
5
3
3
2
1
1
No match
Pharmacology (10)
14
7
5
4
3
2
2
1
1
11
No match
Compounds (22)
28
13
5
5
3
3
3
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
No match
Organisms (12)
19
8
6
5
3
2
2
1
1
1
1
1
No match
50 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
983475
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983487
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1016916
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTON ACID,ISO:CEPHALOTAXINAMIDEHARRINGTONIC ACID,DEOXY:DRUPACINE,NEO:
1007793
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
133127
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
836484
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE,HOMO:HARRINGTONINE,DEOXY:HARRINGTONINE,ISO:HARRINGTONINEHARRINGTONOLIDE
983490
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
133130
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
983476
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
984446
ISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE,HOMO:SCHELHAMMERICINE,3-EPI:DRUPACINECEPHALOTAXINE,EPI:HARRINGTONINE,DEOXY:HARRINGTONINE,ISO:HARRINGTONINECEPHALOTAXINONE,DEMETHYL:
1007794
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
983482
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIMITOTIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983488
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
133126
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
1053184
PRESENT IN (REVIEW)
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
SCHELHAMMERICINE,ISO: CYCLOXY:SCHELHAMMERICINE,3-EPI:CEPHALOTAXINAMIDEDRUPACINEDRUPACINE,NEO: DEMETHYL:CEPHALOTAXINONE,DEMETHYL:HAINANENSINCEPHALOTAXINONEHARRINGTONOLIDE
133131
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONOLIDE
1002507
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
133124
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
1015556
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANENSINE
1002510
PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1002508
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIMITOTIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983477
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1008271
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANENSINE
983483
PHARMACOLOGY OF COMPOUND - IN VIVO
DNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
133125
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
995152
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANENSINE
983489
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983484
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1002506
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1007791
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONOLIDE
133129
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
1016915
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
CEPHALOTAXINONECEPHALOTAXINE,ACETYL: (+):
1002509
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983478
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983481
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIMITOTIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
836483
ISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE,HOMO:HARRINGTONINE,DEOXY:HARRINGTONINE,ISO:HARRINGTONINEHARRINGTONOLIDE
1007796
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
983492
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
994591
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDORD SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE,EPI:HARRINGTONINE
836482
ISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
SCHELHAMMERICINE,ISO: CYCLOXY:SCHELHAMMERICINE,3-EPI:CEPHALOTAXINAMIDEHAINANENSINEHARRINGTONIC ACID,ISO:CEPHALOTAXINONE,DEMETHYL:HARRINGTONIC ACID,DEOXY:HAINANOLIDOL
983486
PHARMACOLOGY OF COMPOUND - IN VIVO
DNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1007792
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
983474
PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1008272
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANENSINE
983485
PHARMACOLOGY OF COMPOUND - IN VIVO
DNA SYNTHESIS INHIBITION
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
1007795
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
133128
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HAINANOLIDOL
983479
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983491
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE
983480
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
HARRINGTONINE